CO4910129A1 - Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina - Google Patents

Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina

Info

Publication number
CO4910129A1
CO4910129A1 CO97071118A CO97071118A CO4910129A1 CO 4910129 A1 CO4910129 A1 CO 4910129A1 CO 97071118 A CO97071118 A CO 97071118A CO 97071118 A CO97071118 A CO 97071118A CO 4910129 A1 CO4910129 A1 CO 4910129A1
Authority
CO
Colombia
Prior art keywords
amphiphilic
indolina
sulfonil
pharmaceutical compositions
compositions containing
Prior art date
Application number
CO97071118A
Other languages
English (en)
Inventor
Jean Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO4910129A1 publication Critical patent/CO4910129A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Sistema solubilizante/estabilizanteanhidro, emulsionable o microemulsionable en agua, para la solubilización de los derivados hidrófobos de N-sulfonil indolina de fórmula: caracterizado porque comprende uno o varios constituyentes elegidos entre compuestos anfífilos, agentes tensioactivos hidrófobos no iónicos y compuestos hidrófilos no iónicos dotados a la vez de propiedades anfifilas y tensioactivas, entendiéndose que dicho sistema comprende ya sea al menos una mezcla de un compuesto anfifilo y un agente tensioactivo hidrófilo no iónico, ya sea al menos un compuesto hidrófilo no iónico dotado a la vez de propiedades tensioactivas y anfífilas.
CO97071118A 1996-12-05 1997-12-04 Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina CO4910129A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
CO4910129A1 true CO4910129A1 (es) 2000-04-24

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97071118A CO4910129A1 (es) 1996-12-05 1997-12-04 Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina

Country Status (25)

Country Link
EP (1) EP0941090A1 (es)
JP (1) JP2000507618A (es)
KR (1) KR20000069308A (es)
CN (1) CN1239887A (es)
AR (1) AR009651A1 (es)
AU (1) AU716575B2 (es)
BR (1) BR9712406A (es)
CA (1) CA2273990A1 (es)
CO (1) CO4910129A1 (es)
DZ (1) DZ2362A1 (es)
EE (1) EE9900206A (es)
FR (1) FR2756736B1 (es)
HU (1) HUP0001386A3 (es)
ID (1) ID23373A (es)
IL (1) IL129936A0 (es)
IS (1) IS5062A (es)
MY (1) MY132819A (es)
NO (1) NO992724D0 (es)
NZ (1) NZ335750A (es)
RU (1) RU2174394C2 (es)
SK (1) SK75599A3 (es)
TR (1) TR199901702T2 (es)
WO (1) WO1998024430A1 (es)
YU (1) YU23099A (es)
ZA (1) ZA9710919B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
JP5767429B2 (ja) 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
BR9712406A (pt) 1999-08-31
WO1998024430A1 (fr) 1998-06-11
EE9900206A (et) 1999-12-15
FR2756736B1 (fr) 1999-03-05
YU23099A (en) 1999-11-22
SK75599A3 (en) 2000-08-14
TR199901702T2 (en) 1999-09-21
NO992724L (no) 1999-06-04
RU2174394C2 (ru) 2001-10-10
NO992724D0 (no) 1999-06-04
HUP0001386A2 (hu) 2001-04-28
EP0941090A1 (fr) 1999-09-15
AU5326298A (en) 1998-06-29
ZA9710919B (en) 1999-06-04
ID23373A (id) 2000-04-20
FR2756736A1 (fr) 1998-06-12
DZ2362A1 (fr) 2002-12-28
AR009651A1 (es) 2000-04-26
CA2273990A1 (fr) 1998-06-11
CN1239887A (zh) 1999-12-29
IL129936A0 (en) 2000-02-29
JP2000507618A (ja) 2000-06-20
HUP0001386A3 (en) 2002-03-28
MY132819A (en) 2007-10-31
IS5062A (is) 1999-06-01
AU716575B2 (en) 2000-03-02
NZ335750A (en) 2001-06-29
KR20000069308A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
CO4910129A1 (es) Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
MX9202166A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes.
BR9916132A (pt) Composições e utilização das mesmas
NO933482L (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
NO990276L (no) Ultralydavbildning av lever
PT975235E (pt) Formulacoes nutricionais contendo oligossacaridos
EA200100105A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ОКСАЗОЛОВ И ТИАЗОЛОВ В КАЧЕСТВЕ АКТИВАТОРОВ hPPAR ГАММА и hPPAR АЛЬФА
BR9914526A (pt) Derivados de adenina
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
ATE233539T1 (de) Schaumförmige lichtzubereitungen mit einem gehalt an wasserlöslichen lichtschutzsubstanzen und grenzflächenaktiven substanzen
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
DE69732571D1 (de) Beta-sulfonyl-hydroxamsäuren als matrix-metalloproteinaseinhibitoren
ES2137625T3 (es) Derivados de 11-(fenil sustituido)estra-4,9-dienos.
PT670162E (pt) Formulacoes farmaceuticas contendo raloxifeno um tensioactivo e um diluente soluvel em agua
NO943762L (no) Indolderivater som 5-HT 1 agonister
CO4340621A1 (es) Complejos de inclusion en solucion acuosa de compuestos de benzotiofeno con ciclodextrinas solubles en agua y sus formulaciones farmaceuticas y procedimietos de los mismos
DK0745388T3 (da) Mammalt vaccinepræparat omfattende squalen eller squalan, phospholipid og et overfladeaktivt stof som adjuvans
MA23403A1 (fr) Emulsions de type huile dans l'eau
AU6469401A (en) Pharmaceutically active compounds and methods of use
RS50002B (sr) Eletriptan hidrobromid monohidrat
ES2115053T3 (es) Derivados indolicos inhibidores de la 5alfa-reductasa de esteroides.
ATE361931T1 (de) N1 modifizierte glycopeptide
CO4750591A1 (es) Procedimiento de lucha contra los insectos